Stefano Menini

Pubblicazioni

Titolo Pubblicato in Anno
TIMP3 overexpression in myeloid lineage alleviates pancreatic damage and confers resistance to the development of type 1 diabetes in the MLDS -induced model FRONTIERS IN ENDOCRINOLOGY 2024
Renal Expression and Localization of the Receptor for (Pro)renin and Its Ligands in Rodent Models of Diabetes, Metabolic Syndrome, and Age-Dependent Focal and Segmental Glomerulosclerosis INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2024
The "sweet" path to cancer: focus on cellular glucose metabolism FRONTIERS IN ONCOLOGY 2023
Food-Related Carbonyl Stress in Cardiometabolic and Cancer Risk Linked to Unhealthy Modern Diet NUTRIENTS 2022
Mutual Regulation between Redox and Hypoxia-Inducible Factors in Cardiovascular and Renal Complications of Diabetes ANTIOXIDANTS 2022
Diabetes and pancreatic cancer-a dangerous liaison relying on carbonyl stress CANCERS 2021
Restoration of renal TIMP3 levels via genetics and pharmacological approach prevents experimental diabetic nephropathy CLINICAL AND TRANSLATIONAL MEDICINE 2021
Diabetic complications and oxidative stress: a 20-year voyage back in time and back to the future ANTIOXIDANTS 2021
Normalizing hif-1α signaling improves cellular glucose metabolism and blocks the pathological pathways of hyperglycemic damage BIOMEDICINES 2021
L-carnosine and its derivatives as new therapeutic agents for the prevention and treatment of vascular complications of diabetes CURRENT MEDICINAL CHEMISTRY 2020
The inflammasome in chronic complications of diabetes and related metabolic disorders CELLS 2020
Diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress in Kras G12D/+mice JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 2020
Galectin-3 gene deletion results in defective adipose tissue maturation and impaired insulin sensitivity and glucose homeostasis SCIENTIFIC REPORTS 2020
Metabolically healthy versus metabolically unhealthy obesity METABOLISM, CLINICAL AND EXPERIMENTAL 2019
Dietary interventions to contrast the onset and progression of diabetic nephropathy. a critical survey of new data CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION 2018
FL-926-16, a novel bioavailable carnosinase-resistant carnosine derivative, prevents onset and stops progression of diabetic nephropathy in db/db mice BRITISH JOURNAL OF PHARMACOLOGY 2018
Galectin-3 is essential for proper bone cell differentiation and activity, bone remodeling and biomechanical competence in mice METABOLISM, CLINICAL AND EXPERIMENTAL 2018
The advanced glycation endproduct Nε-carboxymethyllysine promotes progression of pancreatic cancer: implications for diabetes-associated risk and its prevention JOURNAL OF PATHOLOGY 2018
Natural food sources for the control of glycemia and the prevention of diabetic complications Nutraceuticals and natural product derivatives. Disease prevention and drug discovery 2018
Hepatogenous diabetes. Is it time to separate it from type 2 diabetes? LIVER INTERNATIONAL 2017

ERC

  • LS4
  • LS4_1
  • LS4_7
  • LS4_9
  • LS4_10
  • LS4_12

Interessi di ricerca

Research activities in the fields of diabetes, metabolic disorders, obesity, ageing, and their associated complications, including cancer.

Overall objective: to study of the molecular mechanisms involved in metabolic dysfunctions, alterations in nutritional status, aging and their complications. In particular, the purpose is to provide mechanistic insight into the molecular events involved in the pathogenesis of the cardiometabolic disorders related to the metabolic syndrome and diabetes mellitus (renal disease, atherosclerosis, NASH, and pancreatic cancer) as well as in normal aging process, in order to identify potential molecular target(s) for novel preventive and therapeutic strategies for these conditions.

Specific aims: to investigate the role of the following mechanisms triggering insulin resistance, type 2 diabetes and tissue damage through activation of pro-inflammatory and fibrogenic - redox sensitive - signaling pathways: accumulation of advanced glyco- and lipoxidation end-products (AGEs and ALEs) and signaling through their receptors (galectin-3, RAGE, scavenger receptors, toll-like receptors and NOD-like receptors); the purinergic system and the inflammasome; and the TIMP3/TACE dyad.

Methods: application of cell and molecular biology, morphometric and image analysis techniques to cell culture systems, experimental animal models and human samples.

Keywords

diabetes and metabolism
diabetes complications
cardiometabolic disorders
Advanced glycation end products
oxidative stres
image analysis
Morphometry
obesity
nutrients health conditions

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma